428 related articles for article (PubMed ID: 31379742)
1. Fulminant Type 1 Diabetes Mellitus Caused by Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): A Case Report and Review of the Literature.
Zhu B; Wu J; Chen G; Yang Y; Yi C
Front Endocrinol (Lausanne); 2019; 10():474. PubMed ID: 31379742
[TBL] [Abstract][Full Text] [Related]
2. Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR).
Kano Y; Tohyama M; Aihara M; Matsukura S; Watanabe H; Sueki H; Iijima M; Morita E; Niihara H; Asada H; Kabashima K; Azukizawa H; Hashizume H; Nagao K; Takahashi H; Abe R; Sotozono C; Kurosawa M; Aoyama Y; Chu CY; Chung WH; Shiohara T
J Dermatol; 2015 Mar; 42(3):276-82. PubMed ID: 25623158
[TBL] [Abstract][Full Text] [Related]
3. Drug-Induced Hypersensitivity Syndrome (DIHS)/Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis.
Hama N; Abe R; Gibson A; Phillips EJ
J Allergy Clin Immunol Pract; 2022 May; 10(5):1155-1167.e5. PubMed ID: 35176506
[TBL] [Abstract][Full Text] [Related]
4. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome associated with cefotaxime and clindamycin use in a 6 year-old boy: a case report.
Karakayalı B; Yazar AS; Çakir D; Cetemen A; Kariminikoo M; Deliloglu B; Guven S; Islek I
Pan Afr Med J; 2017; 28():218. PubMed ID: 29629004
[TBL] [Abstract][Full Text] [Related]
5. Current Perspective Regarding the Immunopathogenesis of Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms (DIHS/DRESS).
Miyagawa F; Asada H
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670052
[TBL] [Abstract][Full Text] [Related]
6. A case of drug-induced hypersensitivity syndrome complicated with fulminant type 1 diabetes and type 2 myocardial infarction.
Kobayashi Y; Adachi T; Arakawa H; Minakata Y; Yajima K; Inazumi T
J Dermatol; 2023 Dec; 50(12):1603-1607. PubMed ID: 37563935
[TBL] [Abstract][Full Text] [Related]
7. New Insights into Drug Reaction with Eosinophilia and Systemic Symptoms Pathophysiology.
Musette P; Janela B
Front Med (Lausanne); 2017; 4():179. PubMed ID: 29255708
[TBL] [Abstract][Full Text] [Related]
8. Aggressive treatment in paediatric or young patients with drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS) is associated with future development of type III polyglandular autoimmune syndrome.
Morita C; Yanase T; Shiohara T; Aoyama Y
BMJ Case Rep; 2018 Oct; 2018():. PubMed ID: 30368475
[TBL] [Abstract][Full Text] [Related]
9. Less Known Gastrointestinal Manifestations of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome: A Systematic Review of the Literature.
Jevtic D; Dumic I; Nordin T; Singh A; Sulovic N; Radovanovic M; Jecmenica M; Milovanovic T
J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575398
[TBL] [Abstract][Full Text] [Related]
10. Drug-induced hypersensitivity syndrome: drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome induced by aspirin treatment of Kawasaki disease.
Kawakami T; Fujita A; Takeuchi S; Muto S; Soma Y
J Am Acad Dermatol; 2009 Jan; 60(1):146-9. PubMed ID: 19103366
[TBL] [Abstract][Full Text] [Related]
11. Severe graft-versus-host disease-like enterocolitis accompanied with cytomegalovirus-reactivation in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
Takamiyagi S; Iriki H; Asahina Y; Furuichi Y; Funakoshi T; Ichikawa M; Mikami Y; Okita H; Sakiyama T; Inazumi T; Amagai M; Takahashi H
J Dermatol; 2022 Aug; 49(8):796-799. PubMed ID: 35502510
[TBL] [Abstract][Full Text] [Related]
12. The interferon-γ-induced protein 10/CXCR3 axis is associated with human herpesvirus-6 reactivation and the development of sequelae in drug reaction with eosinophilia and systemic symptoms.
Yang CW; Cho YT; Hsieh YC; Hsu SH; Chen KL; Chu CY
Br J Dermatol; 2020 Nov; 183(5):909-919. PubMed ID: 32037509
[TBL] [Abstract][Full Text] [Related]
13. A Case Report of Fulminant Type 1 Diabetes Mellitus Caused by Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Complicated by Iodine-Induced Thyrotoxicosis.
Wang J; Gao X; Li Y; Ping F
Diabetes Ther; 2019 Jun; 10(3):1145-1150. PubMed ID: 30937841
[TBL] [Abstract][Full Text] [Related]
14. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS): 11 years retrospective study in Thailand.
Hiransuthikul A; Rattananupong T; Klaewsongkram J; Rerknimitr P; Pongprutthipan M; Ruxrungtham K
Allergol Int; 2016 Oct; 65(4):432-438. PubMed ID: 27134114
[TBL] [Abstract][Full Text] [Related]
15. Short- and long-term outcomes of 34 patients with drug-induced hypersensitivity syndrome in a single institution.
Ushigome Y; Kano Y; Ishida T; Hirahara K; Shiohara T
J Am Acad Dermatol; 2013 May; 68(5):721-8. PubMed ID: 23182063
[TBL] [Abstract][Full Text] [Related]
16. Co-Occurrence of Multiple Endocrine Abnormalities Induced by the DIHS/DRESS.
Deng M; Wu H; Yu M; Tian Y; Li Y; Xiao X
Int J Endocrinol; 2019; 2019():7959615. PubMed ID: 31687021
[TBL] [Abstract][Full Text] [Related]
17. Drug Reaction with Eosinophilia and Systemic Symptoms: An Update and Review of Recent Literature.
De A; Rajagopalan M; Sarda A; Das S; Biswas P
Indian J Dermatol; 2018; 63(1):30-40. PubMed ID: 29527023
[TBL] [Abstract][Full Text] [Related]
18. Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) induced by carbamazepine: a case report and literature review.
E L omairi N; Abourazzak S; Chaouki S; Atmani S; Hida M
Pan Afr Med J; 2014; 18():9. PubMed ID: 25360193
[TBL] [Abstract][Full Text] [Related]
19. Case report: Sulfasalazine-induced hypersensitivity.
Kuchinskaya EM; Chikova IA; Kostik MM
Front Med (Lausanne); 2023; 10():1140339. PubMed ID: 37293296
[TBL] [Abstract][Full Text] [Related]
20. Levetiracetam-induced drug reaction with eosinophilia and systemic symptoms syndrome.
Gómez-Zorrilla S; Ferraz AV; Pedrós C; Lemus M; Peña C
Ann Pharmacother; 2012; 46(7-8):e20. PubMed ID: 22764327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
